论文部分内容阅读
目的观察罗哌卡因加芬太尼自控硬膜外镇痛分娩的临床效果。方法选择2011年1—8月180例自控硬膜外镇痛分娩产妇,将其分为治疗组和对照组各90例,治疗组在第一产程活跃期开始施行自控硬膜外镇痛分娩,对照组不使用镇痛治疗,同时记录两组产妇之间的产程、分娩方式、新生儿Apgar评分及产妇产后出血情况。结果治疗组疼痛完全缓解58例,疼痛减轻32例;对照组疼痛均无缓解。两组分娩方式比较差异有统计学意义(P<0.05),两组产程时间、新生儿Apgar评分、产后出血量比较差异均无统计学意义(均P>0.05)。结论在分娩过程中,对产妇使用自控硬膜外镇痛分娩可以有效地缓解产妇疼痛,且对产妇和新生儿无不良影响,值得在临床分娩中推广使用。
Objective To observe the clinical effect of ropivacaine plus fentanyl in controlled epidural analgesia and delivery. Methods From January to August in 2011, 180 cases of self-controlled epidural analgesia delivered women were divided into treatment group and control group, 90 cases each. The treatment group started self-controlled epidural analgesia and delivery in the active phase of the first stage of labor, The control group did not use analgesic treatment, and at the same time, the birth process, delivery mode, neonatal Apgar score and maternal postpartum hemorrhage were recorded. Results In the treatment group, 58 cases were completely relieved of pain and 32 cases were relieved of pain. The pain of the control group was not alleviated. There was significant difference in the mode of delivery among the two groups (P <0.05). There was no significant difference in labor time, Apgar score and postpartum hemorrhage between the two groups (all P> 0.05). Conclusions During delivery, the use of controlled epidural analgesia for delivery can effectively relieve maternal pain without adverse effects on the mothers and newborns. It is worth promoting in clinical delivery.